Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction

被引：0
|
作者：
Rodney A. Appell
机构：
来源：
Current Urology Reports | 2006年 / 7卷 / 5期
关键词：
Urinary Retention; Lower Urinary Tract Symptom; Overactive Bladder; Detrusor Overactivity; Tolterodine;
D O I：
10.1007/s11934-006-0015-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 429
相关论文
共 50 条
  • [31] Tolterodine: A safe and effective treatment for older patients with overactive bladder
    Malone-Lee, JG
    Walsh, JB
    Maugourd, MF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (06) : 700 - 705
  • [32] Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients
    Zinner, NR
    Mattiasson, A
    Stanton, SL
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (05) : 799 - 807
  • [33] Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia
    Nitti, Victor W.
    Dmochowski, Roger
    Appell, Rodney A.
    Wang, Joseph T.
    Bavendam, Tamara
    Guan, Zhonghong
    BJU INTERNATIONAL, 2006, 97 (06) : 1262 - 1266
  • [34] Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder
    Mattiasson, A
    Blaakaer, J
    Hoye, K
    Wein, AJ
    BJU INTERNATIONAL, 2003, 91 (01) : 54 - 60
  • [35] The Antimuscarinic Agent Tolterodine Regulates Bladder Extracellular Matrix in Partial Bladder Outlet Obstruction in Rats
    Yang, Tong-Xin
    Luo, De-Yi
    Lin, Yi-Fei
    Liu, Qiang
    Cai, Xiang
    Ai, Jian-Zhong
    Li, Hong
    Shen, Hong
    Wang, Kun-Jie
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 46 (01) : 36 - 45
  • [36] Benefit-Risk Assessment of Tolterodine in the Treatment of Overactive Bladder in Adults
    Alan D. Garely
    Lara Burrows
    Drug Safety, 2004, 27 : 1043 - 1057
  • [37] Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder
    Drutz H.P.
    Appell R.A.
    Gleason D.
    Klimberg I.
    Radomski S.
    International Urogynecology Journal, 1999, 10 (5) : 283 - 289
  • [38] Improving the Tolerability of Anticholinergic Agents in the Treatment of Overactive Bladder
    Roger Dmochowski
    Drug Safety, 2005, 28 : 583 - 600
  • [39] Antimuscarinic therapy in men with bladder outlet obstruction
    Staskin D.R.
    Kaplan S.A.
    Wein A.J.
    Current Urology Reports, 2006, 7 (6) : 437 - 439
  • [40] Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine
    Kobelt, G
    Kirchberger, I
    Malone-Lee, J
    BJU INTERNATIONAL, 1999, 83 (06) : 583 - 590
12345